Intelligence · Clinical Pipeline
Approved programs Pipeline Programs
ClinicalTrials.gov programs marked approved or launched in registry data.
- Programs
- 1,839
Quick answer
NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.
Top sponsors
- Chinese Academy of 207 programs
- First People's Hospital 186 programs
- Takeda 154 programs
- United Therapeutics Europe 121 programs
- BRIGHT MINDS BIOSCIENCES 116 programs
- Disc Medicine 103 programs
- George Institute for 83 programs
- Hospital Authority 60 programs
- Regeneron UK 60 programs
- Sinovac Research and 47 programs
- Teva Pharma 39 programs
- Pacira Ireland 36 programs
-
Dental foam "Biorepair PERIBIOMA"
The First People's Hospital of Lianyungang
Oral Health
1 trial -
Depo-Medroxyprogesterone Acetate
United Therapeutics Europe Ltd
HIV
1 trial -
Depofoam bupivacaine
Pacira Ireland Limited
Pain, Postoperative
1 trial -
Desipramine
BRIGHT MINDS BIOSCIENCES INC.
Substance-Related Disorders
1 trial -
Desmopressin
The First People's Hospital of Lianyungang
Patients Undergoing Endoscopic Sinus Surgery
1 trial -
Desvenlafaxine Succinate
Grace Therapeutics
Vascular Depression
1 trial -
Deutetrabenazine
Teva Pharma GmbH
Huntington's Disease
1 trial -
Deutetrabenazine Oral Capsule
Teva Pharma GmbH
Tardive Dyskinesia
1 trial -
Dex-Esk
The First People's Hospital of Lianyungang
Older Patients
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
Dexamethasone
The University of Hong Kong
Total Knee Replacement
1 trial -
Dexamethasone
The First People's Hospital of Lianyungang
Carcinoma, Non-Small-Cell Lung
1 trial -
Dexamethasone
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Localized Primary Osteoarthritis of Both Hips (Diagnosis)
1 trial -
Dexamethasone 4 mg tablets, Dexamethasone Phosphate 4 mg/ml Solution for Injection
Disc Medicine
Solid tumors
1 trial -
Dexamethasone and N-acetylcysteine (NAC)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carbon Monoxide Poisoning
1 trial -
Dexamethasone and N-acetylcysteine (NAC)
Hospital Authority, Hong Kong
Carbon Monoxide Poisoning
1 trial -
Dexlansoprazole
Takeda
Gastroesophageal Reflux Disease
4 trials -
Dexlansoprazole 60 MG
Takeda
GERD
1 trial -
Dexmedetomidine
The University of Hong Kong
Anxiety, Separation
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Elderly
3 trials -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lower Limb Fracture
1 trial -
Dexmedetomidine
United Therapeutics Europe Ltd
Breast Cancer
1 trial -
Dexmedetomidine
BioXcel Therapeutics
Schizophrenia Agitation
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Post-Surgical Pain
1 trial -
Dexmedetomidine
Hospital Authority, Hong Kong
Thyroid Diseases
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Older Patients
1 trial -
Dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Thoracic Paravertebral Blocks
1 trial -
Dexmedetomidine
Peking University Third Hospital
Breast Cancer
1 trial -
Dexmedetomidine
Peking University Third Hospital
Aged
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Obstructive Sleep Apnea
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Overall Survival
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Postoperative Delirium After Living Donor Renal Transplantation
1 trial -
Dexmedetomidine
The First People's Hospital of Lianyungang
Renal Function
1 trial -
Dexmedetomidine Group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Dexmedetomidine Injectable Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Epilepsy
1 trial -
Dexmedetomidine-esketamine combination
The First People's Hospital of Lianyungang
Obstructive Sleep Apnea
1 trial -
Dextrose 5%
Hospital Authority, Hong Kong
End-Stage Kidney Disease
1 trial -
Diane-35 pretreatment
The First People's Hospital of Lianyungang
Polycystic Ovary Syndrome
1 trial -
Digaoxin,amiodarone,β receptor antagonist, Calcium Antagonists
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Atrial Fibrillation
1 trial -
Digital Engagement Application (GD App)
Takeda
Gaucher Disease
1 trial -
Digoxin
Teva Pharma GmbH
Heart Failure
1 trial -
Dimethyl fumarate
Biogen
Multiple Sclerosis
1 trial -
Donepezil
Universal Integrated
Total Knee Arthroplasty
1 trial -
Dotarem®
Guerbet
Primary Brain Tumor
1 trial -
Double Blind Varenicline
BRIGHT MINDS BIOSCIENCES INC.
Vaping
1 trial -
Double dose of PPI
Takeda
Dyspepsia
1 trial -
Doxorubicin Accord 2 mg/ml koncentrat till infusionsvätska, lösning, Paclitaxel Accord 6 mg/ml koncentrat till infusionsvätska, lösning, Docetaxel Ebewe 10 mg/ml koncentrat till infusionsvätska, lösning, Epirubicin Accord 2 mg/ml injektions-/infusionsvätska, lösning, Sendoxan pulver till injektionsvätska, lösning
The George Institute
Breast cancer female NOS
1 trial
Frequently asked questions
How many Approved programs pipeline programs are in the directory?
1,839 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources · All pipeline programs